Nanalysis Announces Full Year 2023 Conference Call

Rhea-AI Summary

Nanalysis Scientific Corp. will host a conference call on April 25th to discuss the results for the quarter and year ending December 31, 2023. The Company is a leader in portable NMR machines and MRI technology for industrial and research applications. Investors can participate in the call online or by phone. An additional Q&A session for European investors will be held on April 26th.

Hosting Call at 5:00 pm ET on Thursday, April 25th

European Q&A Session on Friday April 26^th  at 8:30am ET

CALGARY, AB, April 11, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, April 25th, 2024, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter and year ending December 31, 2023. 

Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can also access the call online through a listen-only webcast here:   https://app.webinar.net/9xEage3Q0PB or on the investor relations section of the Company's website HERE.

The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID # 093791.

Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Friday, April 26th which can be accessed by the following link: Join the meeting now 

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis Scientific Corp. operates two primary businesses: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market. 

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.  With its partners, the Company provides scientific equipment sales and maintenance services globally. 

In 2022, through its subsidiary KPrime, the Company was awarded a five-year, $160 million contract with the Government of Canada to provide maintenance services for passenger screening equipment in Canadian airports.  This has resulted in the expansion of the Company's Security Services business.  The Company is providing airport security equipment maintenance services for the Government of Canada in each province and territory of Canada.  In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. 

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-full-year-2023-conference-call-302113992.html

SOURCE Nanalysis Scientific Corp.

When will Nanalysis Scientific Corp. host a conference call to discuss the results for the quarter and year ending December 31, 2023?

Nanalysis Scientific Corp. will host a conference call on Thursday, April 25th, 2024, at 5:00 P.M. Eastern Time.

What is the focus of Nanalysis Scientific Corp. in terms of technology?

Nanalysis Scientific Corp. is a leader in portable NMR machines and MRI technology for industrial and research applications.

How can investors participate in the conference call?

Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad. They can also access the call online through a listen-only webcast.

When will the Q&A session for European investors take place?

The Q&A session for European investors will be held on Friday, April 26th at 8:30am ET.